千金藤素协同多柔比星逆转K562/ADR耐药的分子机制研究

姜秀星; 傅若秋; 高宁

doi:10.16016/j.1000-5404.201807166

您当前的位置：

首页 >

文章列表页 >

千金藤素协同多柔比星逆转K562/ADR耐药的分子机制研究

基础医学 | 更新时间：2026-01-09

- 千金藤素协同多柔比星逆转K562/ADR耐药的分子机制研究
- Molecular mechanism of cepharanthine synergistically acting with doxorubicin in reversing multidrug resistance of K562/ADR cells
- 第三军医大学学报 2018年40卷第23期页码：2154-2161
- 作者机构：
  
  400038 重庆, 陆军军医大学(第三军医大学)药学与检验医学系生药学教研室
- 作者简介：
  
  [ 高宁, E-mail:gaoning59@163.com GAO Ning, E-mail:gaoning59@163.com
- 基金信息：
  
  国家自然科学基金面上项目(31571425)
- DOI：10.16016/j.1000-5404.201807166
  中图分类号： R285.5;R733.7;R915
- 收稿：2018-07-23，
  
  修回：2018-08-24，
  
  纸质出版：2018-12-15
- 稿件说明：
移动端阅览
姜秀星, 傅若秋, 高宁. 千金藤素协同多柔比星逆转K562/ADR耐药的分子机制研究[J]. 第三军医大学学报, 2018,40(23):2154-2161.

Xiuxing JIANG, Ruoqiu FU, Ning GAO. Molecular mechanism of cepharanthine synergistically acting with doxorubicin in reversing multidrug resistance of K562/ADR cells[J]. Journal of Third Military Medical University, 2018, 40(23): 2154-2161.
姜秀星, 傅若秋, 高宁. 千金藤素协同多柔比星逆转K562/ADR耐药的分子机制研究[J]. 第三军医大学学报, 2018,40(23):2154-2161. DOI： 10.16016/j.1000-5404.201807166.

Xiuxing JIANG, Ruoqiu FU, Ning GAO. Molecular mechanism of cepharanthine synergistically acting with doxorubicin in reversing multidrug resistance of K562/ADR cells[J]. Journal of Third Military Medical University, 2018, 40(23): 2154-2161. DOI： 10.16016/j.1000-5404.201807166.

摘要

目的

探讨千金藤素协同多柔比星逆转K562/ADR细胞耐药的分子机制。

方法

MTT法测定K562、K562/ADR细胞存活率; Western blot检测多药耐药蛋白Mdr-1、凋亡相关蛋白以及线粒体分裂关键蛋白Drp1和p-Drp1(Ser637)、线粒体外膜蛋白Tom20蛋白的表达:流式细胞仪检测K562/ADR细胞凋亡以及ROS生成量; 免疫共沉淀技术检测Drp1、Tom20蛋白之间特异性结合。

结果

梯度浓度多柔比星均会降低K562、K562/ADR细胞存活率

两者的IC

值分别为(0.75±0.11)、(75.97±2.17)μmol/L

差异有统计学意义(

0.01)。K562细胞中检测不到多药耐药蛋白

而在K562/ADR细胞中Mdr-1高表达。千金藤素与多柔比星协同作用于K562/ADR细胞

导致K562/ADR存活率明显降低并呈较好的量效关系

协同系数均小于1

K562/ADR细胞凋亡率显著增加(

0.01)。千金藤素与多柔比星协同作用于K562/ADR细胞导致ROS生成量显著升高

Drp1线粒体转位增加。抑制ROS则可阻断两种药物协同作用引起的Drp1线粒体转位

降低K562/ADR细胞凋亡率(

0.01)。

结论

千金藤素协同多柔比星诱导ROS生成促进Drp1线粒体转位

导致线粒体过度分裂和细胞凋亡

最终逆转K562/ADR耐药。

Abstract

Objective

To investigate the molecular mechanism of cepharanthine synergistically acting with doxorubicin in the reverse of multidrug resistance of K562/ADR cells.

Methods

After K562 cells and K562/ADR cells were treated with doxorubicin at various concentration respectively

cell viability was assessed by MTT assay. Then cepharanthine (6 μmol/L)

doxorubicin (4 μmol/L)

NAC (ROC inhibitor

4 μmol/L) alone

or in combination of the former 2 agents or 3 agents together were used to treat the cells respectively. Cell apoptosis and production of reactive oxygen species (ROS) were determined by flow cytometry with Annexin V-/PI staining. The expression of multidrug resistant protein Mdr-1

apoptosis and mitochondrial fission related proteins

Drp1 and p-Drp1 (Ser637)

and translocase of the mitochondrial outer membrane Tom20 were detected by Western blot analysis. Co-immunoprecipitation was used detected the binding of Drp1 and Tom20.

Results

The IC

value of K562 cells to doxorubicin was 0.75±0.11 μmol/L

and that of K562/ADR cells was 75.97±2.17 μmol/L

with significantly difference (

0.01). Mdr-1 was mildly expressed in K562 cells

but was highly expressed in K562/ADR cells. Combined treatment of cepharanthine and doxorubicin resulted in marked decrease in cell viability

which was in a dose-dependent manner and the synergistic coefficient less than 1

and also resulted in increases in apoptotic rate (

0.01) in K562/ADR cells. The synergistic action of the 2 agents also promoted the production of ROS and mitochondrial translocation of Drp1. What's more

inhibiting ROS production by NAC treatment could block the mitochondrial translocation of Drp1 and decrease the apoptotic rate induced by the 2 agents (

0.01).

Conclusion

Cepharanthine synergistically acting with doxorubicin induces the production of ROS and promotes mitochondrial translocation of Drp1

thus results in mitochondrial fission and cell apoptosis

and finally reverses multidrug resistance of K562/ADR cells.

关键词

Keywords

references

WANG J, SEEBACHER N, SHI H, et al. Novel strategies to prevent the development of multidrug resistance (MDR) in cancer[J]. Oncotarget, 2017, 8(48):84559-84571. DOI:10.18632/oncotarget.19187.

WANG Y J,ZHAO H D, ZHU C F, et al.Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR[J].J Cancer, 2017, 8(6): 1103-1112. DOI:10.7150/jca.17688.

FOGARTY C E, BERGMANN A. Killers creating new life:caspases drive apoptosis-induced proliferation in tissue repair and disease[J]. Cell Death Differ, 2017, 24(8): 1390-1400. DOI:10.1038/cdd.2017.47.

GIAMPIETRI C, PETRUNGARO S, PADULA F, et al. Autophagy modulators sensitize prostate epithelial cancer cell lines to TNF-alpha-dependent apoptosis[J]. Apoptosis, 2012, 17(11): 1210-1222. DOI:10.1007/s10495-012-0752-z.

LEE J, LEE D G. Melittin triggers apoptosis in Candida albicans through the reactive oxygen species-mediated mitochondria/caspase-dependent pathway[J]. FEMS Microbiol Lett, 2014, 355(1): 36-42. DOI:10.1111/1574-6968.12450.

PAGLIUSO A, THAM T N, STEVENS J K, et al. A role for septin 2 in Drp1-mediated mitochondrial fission[J]. EMBO Rep, 2016, 17(6): 858-873. DOI:10.15252/embr.201541612.

DESGROUAS C, CHAPUS C, DESPLANS J, et al. In vitro antiplasmodial activity of cepharanthine[J ] . Malar J, 2014, 13: 327. DOI:10.1186/1475-2875-13-327.

WU J, SUZUKI H, ZHOU Y W, et al. Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines[J]. J Cell Biochem, 2001, 82(2): 200-214.

IKEDA R, CHE X, YAMAGUCHI T, et al. Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells[J]. Cancer Sci, 2005, 96(6): 372-376. DOI:10.1111/j.1349-7006.2005.00057.x.

PUGAZHENDHI A, EDISON T N J I, VELMURUGAN B K, et al. Toxicity of Doxorubicin (Dox) to different experimental organ systems[J]. Life Sci, 2018, 200: 26-30. DOI:10.1016/j.lfs.2018.03.023.

FAN Y F, ZHANG W, ZENG L, et al. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters[J]. Cancer Lett, 2018, 421: 186-198. DOI:10.1016/j.canlet.2018.01.021.

TSURUO T, IIDA H, TSUKAGOSHI S, et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil[J ] . Cancer Res, 1981, 41(5): 1967-1972..

CZARNECKA A M, KUKWA W, KRAWCZYK T, et al. Mitochondrial DNA mutations in cancer-from bench to bedside[J]. Front Biosci (Landmark Ed), 2010, 15: 437-460.

JAESCHKE H, MCGILL M R, RAMACHANDRAN A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity[J]. Drug Metab Rev, 2012, 44(1): 88-106. DOI:10.3109/03602532.2011.602688.

NADANACIVA S, DYKENS J A, BERNAL A, et al. Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration[J ] . Toxicol Appl Pharmacol, 2007, 223(3): 277-287. DOI:10.1016/j.taap.2007.06.003.

NEUSTADT J, PIECZENIK S R. Medication-induced mitochondrial damage and disease[J]. Mol Nutr Food Res, 2008, 52(7): 780-788. DOI:10.1002/mnfr.200700075.

ZHANG Z, LIU L, WU S, et al. Drp1, Mff, Fis1, and MiD51 are coordinated to mediate mitochondrial fission during UV irradiation-induced apoptosis[J]. FASEB J, 2016, 30(1): 466-476. DOI:10.1096/fj.15-274258.

ESTAQUIER J, ARNOULT D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis[J]. Cell Death Differ, 2007, 14(6): 1086-1094. DOI:10.1038/sj.cdd.4402107.

OTERA H, MIHARA K. Mitochondrial dynamics: functional link with apoptosis[J]. Int J Cell Biol, 2012, 2012: 821676. DOI:10.1155/2012/821676.

CEREGHETTI G M, STANGHERLIN A, MARTINS DE BRITO O, et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria[J]. Proc Natl Acad Sci U S A, 2008, 105(41):15803-15808.DOI:10.1073/pnas.0808249105.

ZHOU J, LI G, ZHENG Y, et al. A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission[J]. Autophagy, 2015, 11(8): 1259-1279. DOI:10.1080/15548627.2015.1056970.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

MiR-616在骨肉瘤中的表达及对其细胞增殖、凋亡、迁移侵袭的作用

Gm49394对胰岛β细胞凋亡的调控及机制研究

缺氧诱导因子-1α纳米抑制剂的构建及在逆转结直肠癌细胞化疗耐药中的应用

Kallistatin诱导SIRT1表达抑制人髓核细胞凋亡及细胞外基质降解

雷公藤红素通过激活内质网应激介导的细胞凋亡发挥抗ER+乳腺癌的作用